News | November 28, 2011

Fujifilm To Begin Clinical Trials Of 3-D Mammography In The U.S.

 Fujifilm To Begin Clinical Trials Of 3-D Mammography In The U.S.

November 28, 2011 – A year after clinical trials began in Japan, Fujifilm Medical Systems U.S.A. today announced at the Radiological Society of North America (RSNA) 2011 Annual Meeting that clinical trials for their 3-D digital mammography technology are about to commence in the United States. The medical imaging and informatics company is currently installing 3-D mammography systems at renowned medical centers across the country with plans to begin trials as early as December 2011.

“When it comes to the early detection of breast cancer, radiologists will benefit from powerful 3-D technology to elevate their diagnostic confidence, using an average glandular dose that is equivalent to 2-D full field digital mammography (FFDM), increase their workflow, and give their patients improved outcomes,” said David Hotchkiss, director of Modality Solutions Marketing at Fujifilm.  “After thorough evaluation of needs of the patients and clinicians, we believe that, when approved by the FDA, Fujifilm’s 3-D digital mammography has the potential to become the standard of care. We remain committed to improving our breast screening technologies, and we are confident that this will be the screening technology of choice.”

Currently commercially available for sale and in use in Europe, Fujifilm’s 3-D digital mammography is an innovative breast screening technology that presents the images to radiologists in an in-depth, three-dimensional view.  Pairs of stereo images of the breast are acquired and then viewed by combining a 3-D review workstation and dedicated glasses specifically designed to present 3-D breast images.  Because 3-D digital mammography uses the similar clinical workflow as traditional FFDM, and because it presents the stereo images in a standard mammographic view of the breast (e.g., LCC, RCC, LMLO or RMLO) that is familiar for radiologists, it has the potential to increase throughput and diagnostic confidence. The new 3-D system will be especially powerful when viewing overlapping tissue, especially in dense breasts, and will enable radiologists to better visualize abnormalities. This assertion is supported by a previous study of 3-D stereo digital mammography at Emory University that demonstrated a 23 percent increase in sensitivity, and a 46 percent reduction in patient call backs.

According to Satoshi Arakawa, vice president of the Medical Systems Division at Fujifilm Europe, “European clinicians are expressing increased enthusiastic interest in the 3-D system. Initial reports of ongoing studies in Germany indicate that the low-dose 3-D FFDM system has yielded statistically significant reduction in recall rates.”

Images will be acquired with the AspireHD Plus FFDM system upgraded with 3-D capability that will combine the use of innovative Direct Optical Switching (DOS) detector technology and Fujifilm’s legacy 50-micron resolution to produce the image quality and detailed visualization that is particularly critical for interpreting mammography studies.

For more information: www.fujimed.com
 

 

 

Related Content

Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Arterys Demonstrates AI Cloud-Based Medical Image Analysis Solutions at RSNA 2018
News | Computer-Aided Detection Software | November 26, 2018
Medical imaging software company Arterys will demonstrate its wide-ranging suite of artificial intelligence (AI)-...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...